{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Localized Scleroderma in the Pediatric Population
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about the diagnosis, prognosis, and management of localized scleroderma (LSc) in children.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify the pathophysiology, epidemiology, classification, and signs and symptoms of LSc in children.
- Select the diagnosis and management of a child with LSc.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$20.00
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JDNA0120
Published: Jan/Feb 2020
Expires: 1/1/2025
Required Passing Score: 13/18 (72%)
Specialties:
Pediatric,
Primary Care
Topics:
Scleroderma